These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16409186)

  • 1. Inhibitor challenges in the paediatric setting.
    Sieger L; Aledort L
    Haemophilia; 2006 Jan; 12(1):106-7. PubMed ID: 16409186
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.
    Trowbridge CC; Stammers AH; Ciccarelli N; Klayman M
    J Extra Corpor Technol; 2006 Sep; 38(3):254-9. PubMed ID: 17089513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant clotting factor concentrates.
    Lusher JM
    Baillieres Clin Haematol; 1996 Jun; 9(2):291-303. PubMed ID: 8800506
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
    Baudo F; de Cataldo F; Gaidano G;
    Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
    Tarantino M; Aledort L
    Transfusion; 2001 Dec; 41(12):1628-9. PubMed ID: 11778084
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.
    Auerswald G; von Depka Prondzinski M; Ehlken B; Kreuz W; Kurnik K; Lenk H; Scharrer I; Schramm W; Zimmermann R
    Haemophilia; 2004 Sep; 10(5):499-508. PubMed ID: 15357777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 9. Future perspective for the treatment of hemophilia A.
    Laurian Y
    J Thromb Haemost; 2005 Jun; 3(6):1320-1. PubMed ID: 15946228
    [No Abstract]   [Full Text] [Related]  

  • 10. Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?
    Rivard GE; Lillicrap D; Poon MC; Demers C; Lépine M; St-Louis J; Warner M
    Haemophilia; 2005 Jul; 11(4):335-9. PubMed ID: 16011584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
    Fukutake K
    Semin Thromb Hemost; 2000; 26(1):29-32. PubMed ID: 10805278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity.
    Watts RG
    Am J Hematol; 2005 May; 79(1):58-60. PubMed ID: 15849767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.
    Perez R; Martinez RL; Piñero A; Sosa R
    Haemophilia; 2002 Nov; 8(6):822-5. PubMed ID: 12410655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
    Konkle BA; Nelson C; Forsyth A; Hume E
    Haemophilia; 2002 Sep; 8(5):706-10. PubMed ID: 12199684
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac tamponade in a patient with moderate hemophilia A and factor VIII Inhibitors.
    Ghosh N; Teefy P; Laudenbach L; Rivard GE
    Can J Cardiol; 2006 Jan; 22(1):73-5. PubMed ID: 16450022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa (r-FVIIa) in haemophilia management.
    Rice KM; Savidge GF
    Transfus Sci; 1996 Sep; 17(3):339-40. PubMed ID: 10184611
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
    Hedner U
    Semin Thromb Hemost; 2000; 26(4):363-6. PubMed ID: 11092209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.
    Morimoto Y; Yoshioka A; Shima M; Kirita T
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1095-7. PubMed ID: 12966487
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.
    Hedner U; Glazer S; Pingel K; Alberts KA; Blombäck M; Schulman S; Johnsson H
    Lancet; 1988 Nov; 2(8621):1193. PubMed ID: 2903400
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudoprolongation of the prothrombin time during treatment with recombinant factor VIIa for bleeding in a patient with a spontaneous factor VIII inhibitor.
    Carr ME; Kuhn JG; Martin EJ; Tidwell AR; Hagan MK
    Int J Hematol; 2003 Apr; 77(3):308-9. PubMed ID: 12731678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.